34.68

1.37% -0.43

Avidity Biosciences Inc (RNA)

Overview News Price History Option Chain Financials Discussions Forecast

Avidity Biosciences Inc stock is traded at $34.68, with a volume of 766.64K. It is down -1.37% in the last 24 hours and up +12.47% over the past month. Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

Previous Close:

$35.11

Open:

$35.07

24h Volume:

766.64K

Relative Volume:

0.62

Market Cap:

$4.19B

Revenue:

$10.12M

Net Income/Loss:

$-280.49M

P/E Ratio:

-12.00

EPS:

-2.89

Net Cash Flow:

$-188.51M

1W Performance:

+5.16%

1M Performance:

+12.47%

6M Performance:

-15.76%

1Y Performance:

+185.26%

1-Day Range:

$34.39

$35.53

1-Week Range:

$31.47

$35.53

52-Week Range:

$12.02

$56.00

Avidity Biosciences Inc Stock (RNA) Company Profile

Name

Avidity Biosciences Inc

Sector

Healthcare (1187)

Industry

Biotechnology (679)

Phone

858-401-7900

Address

10578 SCIENCE CENTER DRIVE, SAN DIEGO, CA

Employee

253

Twitter

Next Earnings Date

2024-12-07

Latest SEC Filings

RNA's Discussions on Twitter

Compare RNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
RNA Avidity Biosciences Inc	34.68	4.19B	10.12M	-280.49M	-188.51M	-2.89
VRTX Vertex Pharmaceuticals Inc	473.20	123.91B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	716.01	78.94B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	652.71	39.98B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	274.51	35.89B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	118.25	28.75B	3.30B	-501.07M	1.03B	-2.1146

Avidity Biosciences Inc Stock (RNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-20-24	Initiated	H.C. Wainwright	Buy
Nov-26-24	Initiated	RBC Capital Mkts	Outperform
Sep-24-24	Initiated	Goldman	Buy
Aug-28-24	Initiated	Barclays	Overweight
May-03-24	Initiated	BofA Securities	Buy
Mar-14-24	Initiated	Cantor Fitzgerald	Overweight
May-22-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-31-23	Downgrade	Evercore ISI	Outperform → In-line
Jul-20-22	Initiated	Chardan Capital Markets	Buy
Jul-12-22	Initiated	Raymond James	Strong Buy
Sep-07-21	Initiated	Evercore ISI	Outperform
Jun-17-21	Initiated	Needham	Buy
Apr-26-21	Resumed	Credit Suisse	Outperform
Jul-07-20	Initiated	Cowen	Outperform
Jul-07-20	Initiated	Credit Suisse	Outperform
Jul-07-20	Initiated	SVB Leerink	Outperform
Jul-07-20	Initiated	Wells Fargo	Overweight

View All

Avidity Biosciences Inc Stock (RNA) Latest News

Feb 06, 2025

Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 5,875 Shares of Stock - MarketBeat

Feb 06, 2025

RNA Drug Development Pioneer Joins Codexis: Oligonucleotide Expert Who Created First Approved Antisense Drugs - StockTitan

Feb 06, 2025

Feb 05, 2025

Avidity Biosciences chief program officer sells $188,918 in stock - Investing.com India

Feb 05, 2025

Jan 29, 2025

We're Hopeful That Avidity Biosciences (NASDAQ:RNA) Will Use Its Cash Wisely - Yahoo Finance

Jan 29, 2025

Jan 28, 2025

How to Take Advantage of moves in (RNA) - Stock Traders Daily

Jan 28, 2025

Jan 27, 2025

Avidity Biosciences (NASDAQ:RNA) Stock Price Up 6%Here's Why - MarketBeat

Jan 27, 2025

Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat

Jan 27, 2025

Jan 25, 2025

Avidity Biosciences CEO Sarah Boyce sells $297k in stock - MSN

Jan 25, 2025

Avidity Biosciences' chief medical officer sells shares totaling $112,856 - MSN

Jan 25, 2025

Assenagon Asset Management S.A. Invests $1.18 Million in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat

Jan 25, 2025

Jan 24, 2025

Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Michael F. Maclean Sells 3,287 Shares - MarketBeat

Jan 24, 2025

Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 2,959 Shares of Stock - MarketBeat

Jan 24, 2025

Sarah Boyce Sells 10,397 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat

Jan 24, 2025

Avidity Biosciences CHRO Teresa McCarthy sells $84,611 in stock By Investing.com - Investing.com Canada

Jan 24, 2025

Arthur A. Levin Sells 1,872 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat

Jan 24, 2025

Avidity Biosciences chief program officer sells shares worth $206,799 By Investing.com - Investing.com Australia

Jan 24, 2025

Jan 23, 2025

Avidity Biosciences director sells $53,536 in stock By Investing.com - Investing.com Canada

Jan 23, 2025

Avidity Biosciences CFO sells $93,985 in stock By Investing.com - Investing.com Canada

Jan 23, 2025

Avidity Biosciences chief program officer sells shares worth $206,799 - Investing.com India

Jan 23, 2025

Avidity Biosciences CEO Sarah Boyce sells $297k in stock By Investing.com - Investing.com UK

Jan 23, 2025

Avidity Biosciences' chief medical officer sells shares totaling $112,856 By Investing.com - Investing.com UK

Jan 23, 2025

Jan 22, 2025

Analysts Offer Predictions for RNA FY2025 Earnings - MarketBeat

Jan 22, 2025

Leerink Partnrs Has Negative Estimate for RNA Q1 Earnings - MarketBeat

Jan 22, 2025

Jan 21, 2025

Royal Bank of Canada Reiterates Outperform Rating for Avidity Biosciences (NASDAQ:RNA) - MarketBeat

Jan 21, 2025

Jan 20, 2025

Avidity Biosciences Announces Inducement Grants Under Nasdaq Lis - GuruFocus.com

Jan 20, 2025

Exciting News from Avidity Biosciences! New Opportunities Await! - qhubo.com.ni

Jan 20, 2025

Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - StreetInsider.com

Jan 20, 2025

Major Stock Grants Announced! Avidity Biosciences Makes a Bold Move! - Mi Valle

Jan 20, 2025

Jan 17, 2025

12 Biotech Stocks with the Biggest Upside Potential - Insider Monkey

Jan 17, 2025